Regeneron Pharmaceuticals (REGN) Asset Utilization Ratio (2010 - 2026)

Regeneron Pharmaceuticals' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.37 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 2.04% year-over-year to 0.37; the TTM figure through Mar 2026 stood at 0.37 (down 2.04% YoY), while the FY2025 annual figure was 0.37, down 8.65% from the prior year.
• Asset Utilization Ratio was 0.37 for Q1 2026 at Regeneron Pharmaceuticals, up from 0.36 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.52 in Q1 2022 to a low of 0.21 in Q4 2022.
• Historically, Asset Utilization Ratio has averaged 0.37 across 5 years, with a median of 0.38 in 2025.
• The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio slumped 68.08% in 2022, then surged 92.45% in 2023.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.21 in 2022, then soared by 92.45% to 0.4 in 2023, then retreated by 6.07% to 0.38 in 2024, then slipped by 5.92% to 0.36 in 2025, then climbed by 3.13% to 0.37 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.37 (Q1 2026), 0.36 (Q4 2025), and 0.36 (Q3 2025), per Business Quant data.